IBC Life Sciences, Hilton Boston Logan Airport, Boston, MA
October 4-6, 2004
IBC’s annual conference on Formulation Strategies for Protein Therapeutics has become a must-attend for both new and experienced formulation scientists. The meeting offers a combination of in-depth case study presentations from industry experts and discussions on the science behind formulations and protein behavior from leading academics. Highlights of the information you’ll gain from this year’s program include new understandings of the parameters affecting oxidative and photolytic degradation of peptides and proteins in solution and solid state; stabilization strategies to overcome moisture or temperature stress issues for dry powder formulations; spray drying as a process to meet the scale up challenges associated with high concentration protein formulations; inhibiting preservative-induced protein aggregation by increasing the conformational stability of the native state and the intermolecular repulsion between protein molecules; and how to overcome detrimental events during the encapsulation of proteins in hydrophobic polymer matrices used for substantial delivery. Plus, attendees of Formulation Strategies for Protein Therapeutics can attend the sessions of the concurrent Delivery Strategies for Proteins and Peptides at no extra charge. For full conference details and to register, visit www.IBCLifeSciences.com/formulation.
|
|
|
Invited Speakers:
|
|
Keynote Presentations: John Carpenter, Ph.D., Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado David A. Edwards, Ph.D., Gordon McKay Professor of the Practice of Biomedical Engineering, Harvard University Alexander M. Klibanov, Ph.D., Professor of Chemistry & Bioengineering, Massachusetts Institute of Technology Michael J. Pikal, Ph.D., Professor of Pharmaceutics, University of Connecticut W. Mark Saltzman, Ph.D., Goizueta Foundation Professor of Chemical and Biomedical Engineering, Yale University
|
|